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1542 The Journal of Thoracic and CardObjective: Sudden death occurs in as many as 8% of patients after repair of tetralogy
of Fallot and has been attributed to arrhythmias. The purpose of this study was to
establish an animal model to evaluate the individual contribution of different
physiologic sequelae after tetralogy of Fallot repair in the development of late-onset
arrhythmias.
Methods: Forty-nine piglets were divided into 5 groups: (1) pulmonary artery band;
(2) pulmonary valvotomy; (3) pulmonary artery band plus pulmonary valvotomy;
(4) infundibular scar; and (5) age-matched control animals. Baseline and follow-up
electrocardiograms were obtained and recorded, as well as changes in QRS duration.
A total of 45 animals underwent hemodynamic evaluation and programmed elec-
trical stimulation at 5.6 months postoperatively.
Results: Sustained ventricular tachyarrhythmias (ventricular tachycardia/ventricular
fibrillation) were induced in 31.1%, and atrial arrhythmias were induced in 33.3%.
The pulmonary valvotomy group was 30 times more likely to evidence arrhythmias
than control animals for sustained ventricular tachycardia/ventricular fibrillation, as
well as atrial arrhythmias (P .01). The pulmonary artery band group was 15 times
more likely to evidence atrial arrhythmias than control animals (P .02). Prolonged
QRS duration was predictive of inducibility of both atrial arrhythmias (P .01) and
sustained ventricular tachycardia/ventricular fibrillation (P  .01). Mean right atrial
(P  .01) and capillary wedge (P  .01) pressures predicted atrial arrhythmia
inducibility. Right ventricular end-diastolic pressure predicted atrial arrhythmia
(P  .01) and sustained ventricular tachycardia/ventricular fibrillation inducibility
(P  .05). Right ventricular systolic pressure did not predict inducibility of either
atrial arrhythmias (P  .10) or sustained ventricular tachycardia/ventricular fibril-
lation (P  .94).
Conclusions: Chronic right ventricular volume overload resulted in an increased
incidence of inducible ventricular and atrial arrhythmias.
Tetralogy of Fallot (TOF) is the most common cause of cyanotic congenitalheart disease, with a prevalence rate of 0.26 to 0.48 cases per 1000 livebirths.1 In the current surgical era, complete intracardiac repair for TOF is
commonly performed during infancy, with actuarial survival rates of 95% after 5
years and 93% after 30 years.2 Although the long-term mortality rate after TOF
repair is low, late sudden death occurs in approximately 2% to 8% of all postop-
erative patients and has been attributed to ventricular arrhythmias.3-12 The desire to
identify at-risk patients has prompted investigation into potential risk factors leading
to the development of sustained ventricular tachycardia/ventricular fibrillation (VT/
VF). Conflicting data exist regarding the relationship between sustained VT/VF and
right ventricular (RV) systolic hypertension, diastolic hypertension, or both12-17 and
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DRV outflow tract scar or aneurysm.18-21 More recently,
attention has been focused on the contribution of increased
RV volume caused by pulmonary regurgitation (PR) and its
effect on prolongation of ventricular depolarization.9,17,22-24
Studies designed to identify predictive risk factors for
sudden cardiac death (SCD) in patients with TOF have been
retrospective and have involved cohorts of patients with a
variety of hemodynamic lesions. As such, it has been dif-
ficult to analyze individual risk factors and their potential
roles in the development of lethal arrhythmias. A viable and
reproducible animal model was created to mimic physio-
logic sequelae similar to those found after surgical repair of
TOF to evaluate these risk factors independently. During
cardiac catheterization and programmed electrical stim-
ulation, the electrophysiologic effects of RV hyperten-
sion, PR, and scarring caused by a surgical incision in the
RV outflow tract were investigated with respect to arrhyth-
mia inducibility.
Methods
Animal Model
This study surgically established an animal model in which 4
conditions represented the physiologic sequelae after TOF repair:
RV hypertrophy caused by pulmonary stenosis, RV dilatation
caused by PR, RV scar formation (similar to a ventriculotomy),
and a combination of all 3 conditions. The effect of each of these
factors was evaluated 5 to 6 months postoperatively. The animal
model consisted of 4 surgical groups and one control group: (1)
pulmonary artery band (PAB) placement plus infundibular scar;
(2) pulmonary valvotomy (PV) plus infundibular scar; (3) PAB
placement plus PV plus infundibular scar (PAB/PV); (4) infundib-
ular scar only (Scar group), with preservation of the integrity of the
valve annulus; and (5) a control group consisting of age-matched
animals without any intervention purchased from a commercial ven-
dor at 6 months of age.
Anesthesia-sedation
Thirty-five 3- to 7-day-old piglets (2-5 kg) were obtained from a
commercial vendor and studied according to a protocol approved
Abbreviations and Acronyms
AA  atrial arrhythmia
ECG electrocardiogram
OR  odds ratio
PAB  pulmonary artery band
PR  pulmonary regurgitation
PV  pulmonary valvotomy
RV  right ventricular
SCD  sudden cardiac death
TOF  tetralogy of Fallot
VF  ventricular fibrillation
VT  ventricular tachycardiaby the Institutional Animal Care and Use Committee of the Joseph
The Journal of ThoracicStokes Research Institute. The protocol is in compliance with the
National Academy of Science’s “Guide for the Care and Use of
Laboratory Animals” (National Institutes of Health publication no.
96-03, revised 1996). In a fasting state, newborn piglets were
administered a premedication consisting of ketamine, 30 mg/kg,
and acepromazine, 1.2 mg/kg, administered intramuscularly. The
animals were mask ventilated with isoflurane, 2% to 5%, before
endotracheal intubation. Anesthesia was maintained throughout
the procedure with 1% to 2% isoflurane. An intravenous catheter
was placed in an ear vein, and cefazolin, 20 mg/kg, was adminis-
tered. Peripheral oxygen saturation, heart rate, and blood pressure
were monitored noninvasively throughout the procedure. After the
procedure, the animals were extubated and received supplemental
oxygen in an incubator until room air was tolerated. Postoperative
pain management included buprenorphine (Buprenex), 0.1 mg/kg
twice a day for 2 days. Animals were bottle or tube fed until they
could self-feed.
Intraoperative Procedure
All surgical study animals received a muscle-sparing left thoracot-
omy between the fifth or sixth interspace and were then divided
into one of the 4 aforementioned surgical groups. In the PAB and
PAB/PV groups, the PAB was placed by means of circumferential
dissection of the pulmonary artery 1 cm distal to the valve annulus.
After dissection, a ¼-cm umbilical tape was passed around the
artery and secured for a final diameter of approximately 1 cm. In
the PV and PAB/PV groups, a PV was performed by means of
placement of a side-biting Satinsky vascular clamp longitudinally
across the pulmonary valve annulus without obstruction of the RV
outflow tract. A 2-cm incision was made longitudinally across the
pulmonary annulus, and 2 pulmonary valve leaflets were excised.
Next, a 2-cm-long elliptically shaped polytetrafluorethylene patch
was sewn in place with 6-0 nonabsorbable monofilament sutures
across the annulus to ensure complete disruption of valve integrity.
All surgical study groups, including the Scar group, also received
an infundibular scar made by placement of a side-biting vascular
clamp placed longitudinally over the infundibulum without inter-
ruption of the pulmonary valve apparatus. A 1-cm full-thickness
incision was made longitudinally over the infundibulum up to but
not including the valve annulus and then repaired with the place-
ment of a 1-cm-long elliptically shaped polytetrafluorethylene
patch to ensure scar formation. At the completion of each proce-
dure, hemostasis was obtained, and the thoracotomy was closed
over a fully expanded left lung with 2-0 absorbable sutures.
Noninvasive Evaluation
On postoperative days 90 and 180, the animals were sedated for
a transthoracic echocardiogram. Two-dimensional imaging and
color Doppler flow analysis were used to determine the pres-
ence of pulmonary stenosis or pulmonary insufficiency. A 12-
lead electrocardiogram (ECG) was performed preoperatively
and again before cardiac catheterization, except in the control
animals, in which ECGs were obtained only before cardiac
catheterization, to determine the duration of the QRS complex
in leads I, II, V1, and V2. The maximum QRS duration was
used for statistical analysis.
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At a mean interval of 5.6 months after surgical intervention, the
approximate equivalence of swine adulthood,25 the animals were
transferred to the animal catheterization laboratory, where they
were sedated, intubated, and given general anesthesia, as described
above. Vascular access was obtained percutaneously through the
femoral vein and artery and through cut-down to expose the internal
jugular vein. Pressure measurements were recorded in the right
atrium, right ventricle, pulmonary artery, and systemic artery.
Diagnostic electrophysiologic testing was performed according
to the established guidelines outlined in previous studies.6,17,19,26
Quadrapolar electrode catheters were placed in the right atrium
and right ventricle for recording and stimulation. The programmed
electrical stimulation protocol included measurement of the fol-
lowing: (1) baseline intracardiac intervals; (2) sinus node recovery
time at 2 paced cycle lengths; (3) Wenckebach cycle length; and
(4) atrioventricular nodal effective refractory period. Inducibility
of atrial arrhythmias (AAs) was assessed with atrial single and
double premature extrastimuli introduced at 2 drive-train cycle
lengths, followed by burst atrial pacing. Inducibility of ventricular
arrhythmias was assessed with RV apex single and double prema-
ture ventricular extrastimuli at 2 drive-train cycle lengths, followed
by burst ventricular pacing with decrementing cycle lengths to
ventricular refractoriness or to a minimal cycle length of 200 ms.
The ventricular stimulation protocol was performed at the RV
apex. A test result was considered positive if an atrial tachycardia,
VT/VF, or both of greater than 6 beats in duration was induced.
Statistical Analysis
Data analysis occurred in 3 distinct phases. Phase I consisted of
generating frequency counts and measures of central tendency,
variability, and association for all variables in the data set, with
special attention given to 6 specific hemodynamic variables: QRS
duration, systemic blood pressure, right atrial mean pressure, RV
systolic pressure, RV end-diastolic pressure, and pulmonary cap-
illary wedge pressure. Because of the small sample sizes and the
nonnormative nature of the distributions, all summary data re-
ported here are presented as means and medians with their corre-
sponding standard deviations and ranges (Table 1).
Phase II consisted of 2 different subsets of single covariate
TABLE 1. Descriptive statistics and surgical group compa
PAB group PV group
Hemodynamic
outcome
Mean
(SD)
Median
(range)
Mean
(SD)
Median
(range)
Me
(S
QRS 84.3 (5.3) 80.0 (80-90) 83.3 (5.2) 80.0 (80-90) 74.0 (
SBP 74.0 (4.0) 75.0 (65-77) 75.8 (11.0) 75.0 (63-90) 80.0 (
RAP 9.6 (4.7) 9.0 (3-16) 7.7 (3.6) 8.0 (3-12) 8.6 (
RVSP 57.7 (12.1) 60.0 (43-72) 31.7 (13.6) 24.5 (20-54) 57.0 (
RVEDP 10.9 (4.8) 12.0 (3-16) 12.2 (4.4) 13.0 (6-17) 11.4 (
PCWP 14.4 (5.1) 15.0 (6-23) 9.7 (3.2) 10.0 (6-14) 10.6 (
Note: n 45. QRS duration is measured in milliseconds, and pressures are
valvotomy; PAB/PV, pulmonary artery band plus pulmonary valvotomy; S
RAP, right atrial mean pressure; RVSP, right ventricular systolic pressure
wedge pressure.logistic regression models. In the first subset 2 logit models were
1544 The Journal of Thoracic and Cardiovascular Surgery ● Decspecified and tested, specifically to test the relationship between
surgical procedure and the presence or absence of arrhythmias,
first for AA and then for VT/VF. Surgical procedure was dummy
coded as a categoric variable with 5 levels (ie, none [reference
control group], PAB group, PV group, PAB/PV group, and surgi-
cal scar in the outflow tract [Scar group]). In the second subset 2
sets of single covariate logit models were specified and tested with
different electrophysiologic and hemodynamic variables to iden-
tify potential risk factors for arrhythmias. Higher-order interac-
tions between statistically significant risk factors obtained in the
single covariate equations and surgical procedure were investi-
gated but not pursued because of the small sample sizes.
Phase III consisted primarily of secondary analyses in which
the 6 aforementioned hemodynamic measurements were compared
across the 5 surgical groups. Group differences were compared
with respect to 6 specific outcomes (ie, QRS duration, systemic
blood pressure, right atrial mean pressure, RV systolic pressure,
RV diastolic pressure, and pulmonary capillary wedge pressure) by
using the Kruskal-Wallis technique. Follow-up tests were then
conducted between animals in each of the 4 experimental groups
and the control group by using the Wilcoxon rank sum test as
warranted. Nonparametric tests were deemed most appropriate for
these data, given the small sample sizes and the nonnormative
nature of the distributions. Because of the pilot nature of the study,
the hypothesis-wise error rate was not adjusted beyond an  level
of .05. All analyses were conducted with STATA 8.0 software
(STATA Corp, College Station, Tex).
Results
Subject Population
Thirty-five animals underwent an operative procedure, 31 of
which survived to invasive evaluation and were compared
with age-matched control animals. Postoperative deaths oc-
curred in 2 animals in the PAB/PV group and 1 each in the
PV and Scar groups. The mean age at the time of the
invasive evaluation was 5.6 months (standard deviation, 1.3
months). Those animals that underwent catheterization be-
fore 5 months of age were identified by the veterinarian as
s for selected hemodynamic variables
V group Scar group Control group
Median
(range)
Mean
(SD)
Median
(range)
Mean
(SD)
Median
(range)
P
value
70.0 (60-90) 60.8 (8.6) 60.0 (50-70) 71.4 (6.6) 70.0 (60-80) .01
80.0 (70-90) 77.1 (10.2) 75.0 (56-92) 80.4 (9.3) 79.0 (64-98) .48
9.0 (6-10) 4.5 (3.3) 4.0 (1-12) 2.4 (1.5) 2.0 (1-5) .01
50.0 (45-90) 22.1 (8.1) 24.0 (8-37) 18.0 (4.5) 17.5 (12-26) .01
11.0 (10-13) 5.7 (3.9) 5.0 (2-12) 3.9 (1.0) 4.0 (2-5) .01
11.0 (5-14) 7.5 (5.7) 6.0 (1-18) 6.0 (2.1) 6.0 (3-10) .01
ded in millimeters of mercury. PAB, Pulmonary artery band; PV, pulmonary
infundibular scar; SD, standard deviation; SBP, systolic blood pressure;
DP, right ventricular end-diastolic pressure; PCWP, pulmonary capillaryrison
PAB/P
an
D)
15.2)
7.1)
1.5)
18.6)
1.5)
3.4)
recor
car,
; RVEhaving concerning medical issues, including poor feeding
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Dand decreased activity. Seven animals had PAB and scar, 6
animals had PV and scar, 5 animals had combined PAB/PV
plus scar, 13 animals had scar only, and 14 were control
animals. There were 3 iatrogenic deaths, 1 animal in each of
the PAB, Scar, and PAB/PV groups, during the electro-
physiologic study before the ventricular stimulation proto-
col. Causes of iatrogenic death included asynchronous de-
fibrillation of atrial fibrillation (n 2) and excessive energy
used while obtaining ventricular thresholds (n  1).
Electrophysiologic and Hemodynamic Results
The mean QRS duration during infancy before the proce-
dure was 44.4  5.0 ms. At the time of cardiac catheter-
ization, the mean QRS duration was 72.2  11.8 ms, with
a QRS duration of 80 ms or greater in 19 (42.2%) animals.
The mean change in the QRS duration was 27.8  12.0 ms.
Catheterizations were performed on 31 surgically manipu-
lated animals at a mean age of 5.9  1.5 months (range,
3.2-8.1 months) and on 14 control animals at a mean age of
5.5  0.5 months. RV systolic and end-diastolic pressures
were 31.5  19.1 and 7.4  4.6 mm Hg, respectively. All
animals with PAB and animals with PAB/PV demonstrated
greater than one-half systemic RV pressures. Mean filling
pressures in the right atrium were 5.5  4.0 mm Hg, and
pulmonary capillary wedge pressures were 8.8  4.9 mm
Hg. Data stratified according to individual surgical groups
and control animals are shown in Table 1.
Risk Factors for Arrhythmia Vary by Surgical
Substrate
Data on risk factors for arrhythmia by surgical substrate are
shown in Figure 1. Inducible VT/VF occurred in 14 (31.1%)
of the animals undergoing operations. Thirteen of the 14
animals had inducible and hemodynamically unstable ven-
tricular arrhythmias, 7 with polymorphic VT that degener-
Figure 1. Arrhythmia according to surgical group. PAB, Pulmo-
nary artery band group; PV, pulmonary valvotomy group; PAB/PV,
Pulmonary artery band plus pulmonary valvotomy group; Scar,
infundibular scar-only group.ated to VF and 6 with VF. The 14th animal had inducible
The Journal of Thoracicmonomorphic VT lasting 2.1 seconds in duration. There
was no statistical difference between the surgical interven-
tion and the type of ventricular arrhythmia induced.
There was a relationship between the type of operation
and the ability to induce VT (P  .04). VT/VF was induced
in 5 (83%) of 6 animals in the PV group but in only 3 of 13
animals in the Scar group and 2 animals in each of the PAB
(n  7), PAB/PV (n  5), and control (n  14) groups.
Using a logistic regression model with surgical treatment
group as a potential risk factor for VT/VF, animals who
underwent PV were more likely to have inducible VT/VF
compared with the control group (odds ratio [OR], 30; P 
.01; Table 2]. Because of the small number of animals in
each group, significant intergroup comparisons were not
performed.
Inducible AAs occurred in 33.3% (n  15) of the ani-
mals undergoing operations but varied markedly among the
different surgical groups. For example, 5 (71%) of 7 ani-
mals in the PAB group and 5 (83%) of 6 animals in the PV
group had inducible AA, whereas only 3 (23.1%) of 13
animals in the Scar group and 2 (14%) of 14 control animals
had inducible AA. No pig in the combined PAB/PV group
had an inducible AA. When examined by using a single-
covariate logit equation, there was a statistically significant
relationship between surgical treatment and the presence or
absence of AA (P  .01), with a 15-fold increase of risk for
TABLE 2. Logistic regression results for arrhythmia risk
factor models
Model and surgical
group

coefficient
Wald
statistic (z)
Odds ratio
(95% CI)
P
value
Atrial model
Control*
PAB 2.71 2.39 15.0 (1.6-138.2) .02
Scar 0.59 0.58 1.8 (0.2-13.0) .56
PV 3.40 2.55 30.0 (2.2-411.0) .01
PAB/PV†
Intercept 1.79 2.35
Ventricular model
Control*
PAB 0.87 0.77 2.4 (0.36-22.1) .44
Scar 0.59 0.58 1.8 (0.2-13.0) .56
PV 3.40 2.55 30.0 (2.2-411.0) .01
PAB/PV 1.39 1.16 4.0 (0.4-41.2) .24
Intercept 1.79 2.35
Note: n  45 animals. Outcome of interest is either atrial arrhythmia (atrial
model) or ventricular tachycardia/ventricular fibrillation (ventricular
model). CI, Confidence interval; PAB, pulmonary artery band; Scar, infun-
dibular scar; PV, pulmonary valvotomy; PAB/PV, pulmonary artery band
plus pulmonary valvotomy. *Reference group for logistic comparisons.
†PAB/PV group was dropped from the model because of insufficient
variability.animals in the PAB group and a 30-fold increase for animals
and Cardiovascular Surgery ● Volume 130, Number 6 1545
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group (Table 2).
Prognostic Significance of the QRS Duration
Logistic regression analysis demonstrated that a prolonged
QRS duration was predictive of inducibility of AA (P 
.01) and VT/VF (P  .01). Of note, there was a statistically
significant difference in the QRS durations for all surgical
groups when compared with the control animals (P  .01),
except for the PAB/PV group (P  .92). The control ani-
mals did not have neonatal ECGs but can be presumed to
have similar QRS durations to the neonatal animals before
undergoing the surgical procedures. For the entire cohort,
the change in the QRS duration from before surgical inter-
vention to the time of catheterization was 27.8  12.0 ms.
By using single covariate logistic regression models, a
greater change in QRS duration predicted inducibility of
AA (P  .01) and VT/VF (P  .01, Figure 2).
Importance of Increased RV Pressures
RV systolic pressure did not predict inducibility of either
AA (P  .10) or VT/VF (P  .94). However, RV systolic
pressures were significantly increased in all surgical groups
but one when compared with those in the control group (P
 .01, Table 1). The animals in the Scar group were the lone
exception (P  .12). With respect to RV end-diastolic
pressure specifically, a statistically significant relationship
was observed between RV end-diastolic pressure and AA (P
 .01), with a strong trend toward significance for VT/VF
(P  .06). Given this trend, when the iatrogenic causes of
VT/VF are excluded from the analysis, a statistically sig-
nificant relationship between an increased RV end-diastolic
Figure 2. Relationship between change in QRS duration and
arrhythmia inducibility. VT/VF, Ventricular tachycardia/ventricu-
lar fibrillation; AA, atrial arrhythmia.pressure and inducibility of VT/VF was observed (P .05).
1546 The Journal of Thoracic and Cardiovascular Surgery ● DecSimilar to the pattern of findings for RV systolic pressure, a
statistically significant difference in RV end-diastolic pres-
sure was observed between all of the surgical groups but
one and the control group (P  .01). Animals in the Scar
group again proved to be the lone exception (P  .27).
Role of Atrial Compliance
Right atrial mean pressures were significantly associated
with AA (P  .01) but not with VT/VF (P  .07). Simi-
larly, pulmonary capillary wedge pressures were associated
with AA (P  .02) but not with VT/VF (P  .31). Animals
in the PAB, PV, and PAB/PV groups had significantly
higher right atrial mean pressures and significantly higher
capillary wedge pressures than animals in the control groups
(Table 1).
Discussion
Despite the excellent current status of corrective repair of
TOF, late SCD occurs in a significant number of patients
and has been attributed to lethal ventricular arrhythmias.
There has also been some suggestion that AAs might be
lethal in these patients as well. In one of the largest cohort
studies, Gatzoulis and colleagues9 showed an exponentially
increased incidence of VT/VF and SCD with time, reporting
an 11.9% incidence of VT/VF and an 8.3% occurrence of
SCD by age 35 years. In the most recent multicenter cohort
of 252 patients, Khairy and associates7 documented the
occurrence of clinical VT/VF, SCD, or both in 24.6% of
patients.
Over the past several decades, considerable effort has
been made both to identify the substrate for these arrhyth-
mias and to stratify patients according to their risk of
VT/VF and SCD. Potential risk factors for the development
of ventricular arrhythmias have been identified and include
(1) older age at repair and longer duration of postsurgical
follow-up,14-16 (2) frequent ectopic beats,14,17 (3) increased
RV systolic pressure,13-15 (3) increased RV diastolic pres-
sure,13,14 (4) conduction alterations in regions of myocardial
fibrosis,18-21 (5) moderate or severe PR with resultant RV
dilatation,9,15,17,22-24 (6) increased duration of ventricular
depolarization as recorded by QRS duration,7,9,22 and (7)
inducible VT/VF during programmed ventricular stimula-
tion.7,26,27 Although it is likely that the development of
malignant arrhythmias in the patient with TOF postopera-
tively is multifactorial, there have been no controlled pro-
spective studies designed to isolate these individual risk
factors and determine their independent contribution to the
development of significant arrhythmias. In this animal
study, a distinct model of physiologic states in postoperative
TOF was reliably reproduced with RV hypertension, RV
dilation, and scarring in the RV outflow tract. These models
were used to study the effects of each independent variable
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inducible lethal arrhythmias.
In this animal model there was an increased incidence of
ventricular arrhythmias in those animals that underwent the
PV procedure compared with control animals (OR, 30; P 
.011). Neither the Scar group nor the PAB group was
statistically more likely to have VT/VF (OR, 2.4 and 1.8,
respectively) compared with the control group. The animals
that were subject to the combined procedure (PAB/PV) had
a higher likelihood of VT/VF inducibility compared with
the PAB group animals, but this did not reach significance
(OR, 4; P  .24). The single hemodynamic variable that
predicted VT/VF inducibility was an increased RV end-
diastolic pressure.
The importance of RV volume overload and dilation,
presumably caused by PR, tricuspid valve regurgitation, or
both, has been previously suggested as a significant risk
factor in the development of ventricular arrhythmias. Gat-
zoulis and colleagues9 found that QRS duration was related
to RV dilation and that a QRS duration in excess of 180 ms
was predictive of ventricular arrhythmias. No patient with a
QRS duration of less than 180 ms had sustained VT/VF or
SCD (100% sensitive, 94.7% specific). A recent multicenter
analysis reported that a QRS duration of greater than 180 ms
likewise predicted inducibility of VT/VF with programmed
ventricular stimulation (P  .0001).7 This study also indi-
cates that QRS prolongation is a risk factor for VT/VF
(P  .01).
This study demonstrated that there is a significant inci-
dence of inducible AAs in this study population, even in the
absence of a surgical atriotomy. There was a strong rela-
tionship between the type of surgical procedure performed
and the ability to induce AA because animals having PAB
or PV procedures were much more likely to have inducible
AA compared with the control group. Alterations in atrial
and ventricular compliance play a significant role in the
development of AA in the postoperative patient with TOF.
It is common practice at many centers to entirely relieve
RV outflow stenosis at the subvalvar and valvar levels, with
accepted consequences of creating PR and chronic volume
overload.28 This study suggests that RV dilatation is ar-
rhythmogenic and predisposes subjects to potentially lethal
arrhythmias. It is possible that patients with TOF might
benefit from less aggressive measures to relieve pulmonary
stenosis and to maintain the integrity of the pulmonary
valve apparatus after the initial repair. Alternative surgical
approaches that would allow better preservation of pulmo-
nary valve leaflets and limit the degree of PR should be
considered. Parry and coworkers29 reported the success of a
limited transannular patching technique in relieving RV
outflow tract obstruction with the purpose of preserving
pulmonary valvar function as much as possible. Further-
more, early pulmonary valve replacement should be consid-
The Journal of Thoracicered for those patients before progressive RV dilation in an
attempt to protect them from the potential insult of PR and
the risk of SCD. Therrien and associates30 found that pul-
monary valve replacement in this patient population led to
the stabilization of the QRS duration and, with concurrent
intraoperative cryoablation, a significant reduction in the
incidence of both atrial and ventricular arrhythmias. Re-
cently, interest has developed in newer approaches, such as
the placement of percutaneous pulmonary valves31 in the
cardiac catheterization laboratory, to reestablish pulmonary
valve competency while avoiding the surgical risk inherent
with reoperation.
Study Limitations
Although this study creates similar physiology to postoper-
ative TOF, it does not include the anatomic or genetic
substrate, such as malalignment of the ventricular septum,
ventricular septal defect, or subvalvar pulmonary stenosis.
Any additional contribution of the anatomy and genetic
alterations to the development of late arrhythmias are not
accounted for in this study. A final limitation in the design
of the study is the duration of follow-up after neonatal
cardiac surgery. Although this study follows the animals to
early adulthood, late-onset lethal arrhythmias might progress
more insidiously and do not become manifest until late
adulthood.
Conclusions
In this prospective animal study a reproducible pig model
was created to study the roles of RV hypertension, severe
PR, and scarring in the RV outflow tract and their contri-
bution to the development of atrial and ventricular arrhyth-
mias. In this model, chronic RV volume overload and RV
dilation caused by free PR appear to establish the necessary
electrophysiologic and hemodynamic conditions to induce
and sustain significant atrial and ventricular tachyarrhyth-
mias. Furthermore, residual hemodynamic lesions resulting
in an increased RV end-diastolic pressure are associated with
an increased incidence of inducible arrhythmias. Lastly, RV
hypertension and RV dilation both appear related to the
development of AAs. These results suggest that aggressive
management strategies aimed at reducing RV volume bur-
den, size, or both are warranted in patients who have un-
dergone surgical correction of TOF with the goal to prevent
VT/VF and SCD.
We thank Peggy McCann for her assistance in obtaining the
echocardiographic images, David Riffe for assistance in recording
numerous ECGs, and David Donnelley for technical support dur-
ing the invasive hemodynamic evaluations.
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